Jotam G. Pasipanodya

Author

Also Known As

B. Magazi, J. G. Pasipanodya, J. Pasipanodya, J.G. Pasipanodya, Jotam G Pasipanodya, Jotam G Pasipanodya(New Corresponding Author), Jotam G. Pasipanodya, Jotam Garaimunashe Pasipanodya, Jotam Pasipanodya

123

Publications

Citations

H-Index

Concepts

All Affiliations

Baylor University Medical Center University of Cape Town The University of Texas Southwestern Medical Center Johns Hopkins University Johns Hopkins Medicine

About

Jotam G. Pasipanodya is an author at Baylor University Medical Center specializing in tuberculosis, medicine, and drug resistance.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	18	18	1.1K
2	Health Sciences	8	8	316
3	Public Health	2	2	123
4	Health Informatics	1	1	84
5	Health Law	1	1	24

Jotam G. Pasipanodya

Publications

4.1K

Citations

H-Index

Page 1

	Year	Citations
Serum Drug Concentrations Predictive of Pulmonary Tuberculosis Outcomes Jotam G. Pasipanodya, Helen McIlleron, A. Burger, The Journal of Infectious Diseases	2013	447
Multidrug-Resistant Tuberculosis Not Due to Noncompliance but to Between-Patient Pharmacokinetic Variability Shashikant Srivastava, Jotam G. Pasipanodya, Claudia Meek, The Journal of Infectious Diseases	2011	270
Post-tuberculosis lung health: perspectives from the First International Symposium Brian Allwood, Marieke M. van der Zalm, André F.S. Amaral, The International Journal of Tuberculosis and Lung Disease	2020	241
Pulmonary Impairment After Tuberculosis Jotam G. Pasipanodya, Thaddeus L. Miller, Mauricio Vecino, CHEST Journal Pulmonary TuberculosisPulmonary CarePulmonary PathologyTuberculosis PreventionPulmonary Impairment	2007	239
Drug-Penetration Gradients Associated with Acquired Drug Resistance in Patients with Tuberculosis Keertan Dheda, Laura Lenders, Gesham Magombedze, American Journal of Respiratory and Critical Care Medicine	2018	160
Impact of Nonlinear Interactions of Pharmacokinetics and MICs on Sputum Bacillary Kill Rates as a Marker of Sterilizing Effect in Tuberculosis Emmanuel Chigutsa, Jotam G. Pasipanodya, Marianne E. Visser, Antimicrobial Agents and Chemotherapy Tuberculosis PreventionAntimicrobial ChemotherapyNonlinear InteractionsPhysiologically-based Pharmacokinetic ModelingPharmacodynamic Modeling	2014	132
Pulmonary impairment after tuberculosis and its contribution to TB burden Jotam G. Pasipanodya, Scott J.N. McNabb, Peter E. Hilsenrath, BMC Public Health	2010	128
Drug Concentration Thresholds Predictive of Therapy Failure and Death in Children With Tuberculosis: Bread Crumb Trails in Random Forests Soumya Swaminathan, Jotam G. Pasipanodya, Geetha Ramachandran, Clinical Infectious Diseases	2016	120
Linezolid Dose That Maximizes Sterilizing Effect While Minimizing Toxicity and Resistance Emergence for Tuberculosis Shashikant Srivastava, Gesham Magombedze, Thearith Koeuth, Antimicrobial Agents and Chemotherapy	2017	110
Using the St. George Respiratory Questionnaire To Ascertain Health Quality in Persons With Treated Pulmonary Tuberculosis Jotam G. Pasipanodya, Thaddeus L. Miller, Mauricio Vecino, CHEST Journal Ascertain Health QualityPulmonary TuberculosisPulmonary CareTreated Pulmonary TuberculosisTuberculosis Prevention	2007	99

Page 1